Katherine Rowe

Katherine (Kathy) S. Rowe, MD, is a consultant paediatrician at the University of Melbourne Royal Children's Hospital, Victoria, Australia, and an expert in the area of ME/CFS and the relationship between health and education. She has learned much from her extensive cohort and feedback from the young people with this illness.

2017 Pediatric Primer
Dr. Katherine Rowe was one of the authors of the 2017 Pediatric Primer published in Frontiers in Pediatrics.
 * Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer by Peter Rowe, Rosemary A. Underhill, Kenneth J. Friedman, Alan Gurwitt, Marvin S. Medow, Malcolm S. Schwartz, Nigel Speight, Julian M. Stewart, Rosamund Vallings and Katherine S. Rowe (Full Text)

IOM Committee on Diagnostic Criteria for ME/CFS
Dr Rowe was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Pediatric case definition

 * 2006, A Pediatric Case Definition for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (Full Text)

ME/CFS Common Data Element (CDE) Project
Member of the Sleep Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Talks and Interviews

 * 2014, Dr Kathy Rowe at a seminar put on by [[Emerge Australia] (formerly ME/CFS Australia (Victoria)).]
 * 2007, Panel on "Chronic fatigue syndrome," interviewed by Natasha Mitchell on All in the Mind on ABC Radio National Australia

Notable studies

 * 2009, Severe versus Moderate criteria for the new pediatric case definition for ME/CFS (Abstract)
 * 1999, Five-Year Follow-Up of Young People with Chronic Fatigue Syndrome Following the Double Blind Randomised Controlled Intravenous Gammaglobulin Trial.
 * 1997, Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents.